Tempest Therapeutics Inc. Gains 2879.17%
Wed, Oct 11, 2023 at 07:25 PM
Tempest Therapeutics Inc. (TPST:NASDAQ) shot up at $7.15, a gain of 2879.2%. On Wed, Oct 11, 2023, TPST:NASDAQ touched a New 2-Week High of $7.15. The stock appeared on our News Catalysts scanner on Wed, Oct 11, 2023 at 12:01 PM in the 'BIOTECH' category. From Wed, Sep 27, 2023, the stock recorded 10.00% Up Days and 9.09% Green Days
About Tempest Therapeutics Inc. (TPST:NASDAQ)
Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific...
Top 10 Gainers:
- Tempest Therapeutics Inc. (TPST:NASDAQ), 2879.17%
- Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT), 313.55%
- Phio Pharmaceuticals Corp. (PHIO:NASDAQ), 91.18%
- Tupperware Brands Corporation (TUP:NYSE), 55.33%
- Athena Consumer Acquisition Corp. Class A (ACAQ:NYSEMKT), 54.44%
- Athena Consumer Acquisition Corp. Class A (ACAQ:NYSE), 54.44%
- Asset Entities Inc. (ASST:NASDAQ), 45%
- XORTX Therapeutics Inc. (XRTX:NASDAQ), 41.3%
- Bird Global Inc. Class A (BRDS:NYSE), 34.44%
- voxeljet AG (VJET:NASDAQ), 33.98%